Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shin-ichiro Miyagawa is active.

Publication


Featured researches published by Shin-ichiro Miyagawa.


British Journal of Haematology | 2000

Insulin and insulin‐like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors

Shin-ichiro Miyagawa; Masao Kobayashi; Nakao Konishi; Takashi Sato; Kazuhiro Ueda

The effects of insulin and insulin‐like growth factor I (IGF‐I) on the proliferation of erythroid progenitor cells in bone marrow were studied in serum‐deprived culture. Primitive human bone marrow cells were purified by cell sorting on the basis of the expression of CD34 and the Kit receptor. Insulin and IGF‐I with erythropoietin (EPO) dose dependently supported the formation of erythroid colonies of CD34+/Kit+ cells in bone marrow. The direct effect of insulin and IGF‐I on the stimulation of primitive erythroid progenitor cells was confirmed by single‐cell proliferation studies in serum‐deprived liquid suspension culture. The addition of insulin and/or IGF‐I to stem cell factor (SCF) resulted in an additive increase in the number of erythroid colonies. The erythroid colonies formed by insulin and IGF‐I with EPO were different in size from those formed by SCF with EPO. These findings imply that erythroid progenitor cells responding to insulin and IGF‐I might be at a different developmental stage of erythropoiesis from those responding to SCF in CD34+/Kit+ cells. Similarly, insulin and IGF‐I with EPO supported the proliferation of the mature erythroid progenitor cells in light‐density bone marrow mononuclear cells (LDBMCs). The addition of the anti‐receptor antibody to IGF‐I receptor or insulin receptor partially suppressed erythroid colony formation supported with insulin or IGF‐I in both CD34+/Kit+ cells and LDBMCs. The simultaneous addition of both receptor antibodies completely abrogated the erythroid colony formation. These results suggest that insulin and IGF‐I directly stimulate the proliferation of the late stage of primitive erythroid progenitor cells and mature erythroid progenitor cells through the sharing of receptors.


Journal of Leukocyte Biology | 2003

Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia

Hiroshi Kawaguchi; Masao Kobayashi; Kazuhiro Nakamura; Nakao Konishi; Shin-ichiro Miyagawa; Takashi Sato; Hidemi Toyoda; Yoshihiro Komada; Seiji Kojima; Yukiko Todoroki; Kazuhiro Ueda; Osamu Katoh

We examined the expression of granule constituent genes in myeloid progenitor cells during proliferation and differentiation in patients with severe congenital neutropenia (SCN). The heterozygous mutation of the neutrophil elastase gene was identified in two of four patients. The CD34+/granulocyte‐colony stimulating factor receptor (G‐CSFR)+ cells of SCN patients showed defective responsiveness to G‐CSF in serum‐deprived culture. The CD34+/G‐CSFR+ cells expressed low levels of the granule constituent mRNAs. The transcription levels of primary granule enzyme genes in CD34+/G‐CSFR+ cells were gradually enhanced and then decreased when cells were induced toward myeloid lineage with G‐CSF in normal subjects. However, the primary up‐regulation and the following down‐regulation of these enzyme transcriptions were not clearly observed in SCN patients. No differences in expressions of the lactoferrin gene were seen between normal subjects and patients with SCN. We hypothesize that the abnormal regulation of the transcription in primary granule constituents might involve the defective proliferation and differentiation of myeloid cells in patients with SCN.


Hormone Research in Paediatrics | 2007

Steroid-Dependent ACTH-Produced Thymic Carcinoid: Regulation of POMC Gene Expression by Cortisol via Methylation of Its Promoter Region

Yoko Mizoguchi; Teruyuki Kajiume; Shin-ichiro Miyagawa; Satoshi Okada; Yoshikazu Nishi; Masao Kobayashi

Aims: Metyrapone causes a decrease in the serum cortisol level without affecting ACTH production in ectopic tumors. We report a case who presented with Cushing’s syndrome due to an ectopic ACTH-producing thymic carcinoid. In the present case, it was demonstrated that metyrapone administration resulted in a significant decrease in the plasma ACTH and serum cortisol levels. We hypothesized that the steroid hormone may promote proopiomelanocortin (POMC) gene expression in the carcinoid cells. Methods: An 11-year-old boy presented with Cushing’s syndrome. Prior to the detection of a thymic tumor, metyrapone was administered to ameliorate the symptoms of Cushing’s syndrome. Interestingly, plasma ACTH as well as serum cortisol levels immediately decreased after metyrapone administration. The levels of cortisol and ACTH were observed to be normal after complete surgical resection of the tumor. Biological characterization of the tumor cells was by in vitro analysis. Results: Thein vitro culture of the tumor cells showed an increased expression of POMC in the presence of cortisol. A CpG methylation assay showed that the demethylation of the POMC promoter was induced by a steroid hormone. Conclusion: These findings suggest that the ectopic ACTH-producing tumor may partly be regulated by the elevated levels of cortisol.


Clinical Pediatric Endocrinology | 2010

Clinical Characteristics of Perinatal Lethal Hypophosphatasia: A Report of 6 Cases

Akari Nakamura-Utsunomiya; Satoshi Okada; Keiichi Hara; Shin-ichiro Miyagawa; Kanae Takeda; Rie Fukuhara; Yusei Nakata; Michiko Hayashidani; Kanako Tachikawa; Toshimi Michigami; Keiichi Ozono; Masao Kobayashi

Hypophosphatasia is a rare inherited disorder caused by deficient tissue-nonspecific alkaline phosphatase activity. It is classified into 6 subtypes, and the perinatal lethal form of hypophosphatasia is the most severe. Patients with this form suffer from various symptoms, including respiratory failure, premature craniosynostosis, rachitic changes in the metaphyses, convulsions and hypercalcemia. This report presents 6 cases of the perinatal lethal form of hypophosphatasia. All of the patients showed shortening of the long bones in utero in ultrasonographic examinations. Two of the six patients died at birth because they could not establish spontaneous breathing. Three of the remaining four patients also died before 1 yr of age. The major cause of death was respiratory failure due to hypoplastic lung. All of the patients, except for the two who died at birth, experienced convulsions in their clinical courses. Vitamin B6 therapy effectively reduced the frequency and severity of convulsions. However, it could not always make the patients convulsion free. Three patients underwent a genetic analysis. The 1559delT mutation, which abolishes Alkaline Phosphatase (ALP) activity, was a hot spot. A homozygous 1559delT mutation was observed in two patients. However, they differed in severity of symptoms. Although a good genotype-phenotype correlation has been reported in hypophosphatasia, the genotype alone does not always predict the life span of the patients. These cases therefore suggested the importance of genetic counseling.


International Journal of Hematology | 2005

A Case of Adolescent Primary Adrenal Natural Killer Cell Lymphoma

Yoko Mizoguchi; Kazuhiro Nakamura; Shin-ichiro Miyagawa; Shin-Ichiro Nishimura; Koji Arihiro; Masao Kobayashi

Primary adrenal lymphoma is uncommon, and the majority cases of this disorder are found in elderly individuals. We describe a 17-year-old boy with persistent fever, hemophagocytic lymphohistiocytosis, and a bilateral tumor of the adrenal glands. The disease was progressive and did not respond to treatment such as immunosuppression therapy or plasma exchange. Postmortem analysis revealed nasal-type natural killer cell lymphoma in association with Epstein-Barr virus infection. To our knowledge, this case is the first of primary adrenal lymphoma with the natural killer cell phenotype to be reported. The characterization of this unusual case should be included in the differential diagnosis of adrenal gland tumors.


Pediatrics International | 2009

Successful bone marrow transplantation in chronic granulomatous disease

Mizuka Miki; Atsushi Ono; Ayumi Awaya; Shin-ichiro Miyagawa; Rie Onodera; Emi Kurita; Asako Hiraoka; Fumio Hidaka; Tomoyuki Mizukami; Hiroyuki Nunoi; Masao Kobayashi

WC. Urinary tract infections due to Candida albicans. Rev. Infect. Dis. 1982; 4: 1107–18. 3 Wimalendra M, Reece A, Nicholl RM. Renal fungal ball. Arch. Dis. Child. Fetal Neonatal Ed. 2004; 89: F376. 4 Blanc PL, Berne D, Annweiler M, Marc JM, Béal A, Bedock B. [Candidal bezoar of the urinary tract during Candida albicans septicemia]. Nephrologie 1993; 14: 19–22. 5 Jantausch B, Kher K Urinary tract infections. In: Kher K, Schnaper HW, Makker SP (eds). Clinical Pediatric Nephrology, 2nd edn. Informa UK, Abingdon, Oxon, 2007; 553–74. 6 Krishnamurthy R, Aparajitha C, Abraham G, Shroff S, Sekar U, Kuruvilla S. Renal aspergillosis giving rise to obstructive uropathy and recurrent anuric renal failure. Geriatr. Nephrol. Urol. 1998; 8: 137–9. 7 Baetz-Greenwalt B, Debaz B, Kumar ML. Bladder fungus ball: A reversible cause of neonatal obstructive uropathy. Pediatrics 1988; 81: 826–9. 8 Sánchez Sanchís M, Pastor Lence J, San Juan de Laorden C, Llopis Guixot B, Tarin Planes M, Carrascosa Lloret V. [Candidiasis of the upper urinary tract. Report of a case]. Arch. Esp. Urol. 1996; 49: 66–8. 9 Alkalay AL, Srugo I, Blifeld C, Komaiko MS, Pomerance JJ. Noninvasive medical management of fungus ball uropathy in a premature infant. Am. J. Perinatol. 1991; 8: 330–2. 10 Hershman-Sarafov M, Tubi O, Srugo I, Bader D. [Fungus-ball in a preterm infant successfully treated with fluconazole]. Harefuah 1998; 134: 28–30. 11 Burguet A, Menget A, Fromentin C, Aubert D, Costaz R, Lemouel A. [Anuria in an infant caused by an intrapyelic mycelial bezoar in a solitary kidney]. Arch. Fr. Pediatr. 1988; 45: 341–2. 12 Alvarez Kindelán J, Alameda Aragonéses V, Regueiro López JC et al. [Management of obstructive renal candidiasis. Report of a clinical case]. Actas Urol. Esp. 1997; 21: 290–92. 13 Levin DL, Zimmerman AL, Ferder LF, Shapiro WB, Wax SH, Porush JG. Acute renal failure secondary to ureteral fungus ball obstruction in a patient with reversible deficient cell-mediated immunity. Clin. Nephrol. 1975; 4: 202–10. 14 Navarro Sebastián J, Hidalgo Togores L, Cárcamo Valor P et al. [Renal candidiasis: Percutaneous endoscopic treatment of the pyeloureteral fungus-ball]. Arch. Esp. Urol. 1990; 43: 543–9. 15 Martínez Bengoechea J, Allepuz Losa C, Gil Sanz MJ, Minguez Pemán J, Rioja Sanz LA. [Systemic candidiasis and ureteral fungus ball. Ketoconazole and irrigating solutions in the management of urinary candidiasis]. Actas Urol. Esp. 1990; 14: 314–18. 16 Prat O, Schurr D, Pomeranz A, Farkas A, Drukker A. Renal candidiasis in infancy: A case with fungus ball obstruction. Int. J. Pediatr. Nephrol. 1984; 5: 223–6. 17 Lo Cascio M, Podestà E, Fatta G, De Angelis M, Toma P. [A rare cause of urologic emergency in childhood: Obstruction of the urinary tract caused by Candida]. Pediatr. Med. Chir. 1987; 9: 239–42. 18 Burgués Gasión JP, Alapont Alacreu JM, Oliver Amorós F, Benedicto Redón A, Boronat Tormo F, Jiménez Cruz JF. [Pyeloureteral fungus ball in patients with urinary lithiasis. Treatment with ureterorenoscopy]. Actas Urol. Esp. 2003; 27: 60–64. 19 Montalvo JA, Montaner A, Torino JR, Ribó JM, Morales L. [Obstructive candidiasis: A process with surgical solution]. Cir. Pediatr. 1994; 7: 204–6. 20 Fisher J, Mayhall G, Duma R, Shadomy S, Shadomy J, Watlington C. Fungus balls of the urinary tract. South. Med. J. 1979; 72: 1281–4. 21 Abramowitz J, Fowler JE, Talluri K et al. Percutaneous identification and removal of fungus ball from renal pelvis. J. Urol. 1986; 135: 1232–3. 22 Menéndez López V, Elia López M, Llorens Martínez FJ, Galán Llopis JA, de Nova Sánchez E, García López F. [Treatment of pelvis fungus ball with ureteral catheterization, fluconazole, and urine alkalinization]. Actas Urol. Esp. 1999; 23: 167–70. 23 Benjamin DK Jr, Fisher RG, McKinney RE Jr, Benjamin DK. Candidal mycetoma in the neonatal kidney. Pediatrics 1999; 104: 1126–9. 24 Biyikli NK, Tugtepe H, Akpinar I, Alpay H, Ozek E. The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis. Pediatr. Nephrol. 2004; 19: 801–4.


Frontiers in Genetics | 2017

Individual Clinically Diagnosed with CHARGE Syndrome but with a Mutation in KMT2D, a Gene Associated with Kabuki Syndrome: A Case Report

Sonoko Sakata; Satoshi Okada; Kohei Aoyama; Keiichi Hara; Chihiro Tani; Reiko Kagawa; Akari Utsunomiya-Nakamura; Shin-ichiro Miyagawa; Tsutomu Ogata; Haruo Mizuno; Masao Kobayashi

We report a Japanese female patient presenting with classic features of CHARGE syndrome, including choanal atresia, growth and development retardation, ear malformations, genital anomalies, multiple endocrine deficiency, and unilateral facial nerve palsy. She was clinically diagnosed with typical CHARGE syndrome, but genetic analysis using the TruSight One Sequence Panel revealed a germline heterozygous mutation in KMT2D with no pathogenic CHD7 alterations associated with CHARGE syndrome. Kabuki syndrome is a rare multisystem disorder characterized by five cardinal manifestations including typical facial features, skeletal anomalies, dermatoglyphic abnormalities, mild to moderate intellectual disability, and postnatal growth deficiency. Germline mutations in KMT2D underlie the molecular pathogenesis of 52–76% of patients with Kabuki syndrome. This is an instructive case that clearly represents a phenotypic overlap between Kabuki syndrome and CHARGE syndrome. It suggests the importance of considering the possibility of a diagnosis of Kabuki syndrome even if patients present with typical symptoms and meet diagnostic criteria of CHARGE syndrome. The case also emphasizes the impact of non-biased exhaustive genetic analysis by next-generation sequencing in the genetic diagnosis of rare congenital disorders with atypical manifestations.


Pediatrics International | 2013

Management of advanced-stage neuroblastoma in a patient with 21-hydroxalase deficiency

Akari Utsunomiya; Satoshi Okada; Keiichi Hara; Mizuka Miki; Yoko Mizoguchi; Yoshiyuki Kobayashi; Shin-ichiro Miyagawa; Kazuhiko Jinno; Kazuhiro Nakamura; Takashi Sato; Masao Kobayashi

A 2‐year‐old boy presented with a 21‐hydroxylase deficiency, associated with advanced‐stage neuroblastoma primarily occurring in the left adrenal gland. He required intensive chemotherapy with polypharmacy, followed by cord blood stem cell transplantation to treat the neuroblastoma. The precise adjustment of cortisol levels was crucial in this patient to prevent adrenal crisis. We administered hydrocortisone by continuous infusion while monitoring blood cortisol levels. As there are no published reports on the target cortisol levels for children, we used two control infants with advanced‐stage neuroblastoma, also undergoing chemotherapy and cord blood stem cell transplantation, to guide the continuous hydrocortisone therapy. The daily dose of hydrocortisone during chemotherapy required about threefold the normal treatment to avoid adrenal insufficiency. Continuous hydrocortisone therapy is feasible for preventing adrenal crisis and this report may provide an effective management for hydrocortisone replacement in 21‐hydroxylase‐deficient patients undergoing chemotherapy and hematopoietic stem cell transplantation.


European Journal of Endocrinology | 1993

Growth hormone therapy in achondroplasia

Yoshikazu Nishi; Michi Kajiyama; Shin-ichiro Miyagawa; Mitsuhiro Fujiwara; Kazuko Hamamoto


Blood | 1999

Defective Proliferation of Primitive Myeloid Progenitor Cells in Patients With Severe Congenital Neutropenia

Nakao Konishi; Masao Kobayashi; Shin-ichiro Miyagawa; Takashi Sato; Osamu Katoh; Kazuhiro Ueda

Collaboration


Dive into the Shin-ichiro Miyagawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge